
So pleased that our #NLP product CLAMP did so well in this #FDA study reported in the journal Drug Safety
Melax Tech, now part of IMO@MelaxTech
Our #NLP work was featured among 13 companies participating in #FDA study on #TextProcessing for #AdverseDrugEvents. Our system was recognized for its ability to capture relevant textual data to improve #pharmacovigilance. lnkd.in/e5YmnWc
English

